Vimarsana
Biggest News Aggregation in the World

Page 30 - Twist Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Twist Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Twist Bioscience Today - Breaking & Trending Today

Twist Bioscience Co. (NASDAQ:TWST) Receives $26.17 Average Target Price from Analysts - Vimarsana News

Twist Bioscience Co. (NASDAQ:TWST) Receives $26.17 Average Target Price from Analysts

Shares of Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) have been assigned an average rating of “Moderate Buy” from the six analysts that are currently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average […]

Cloning And Mutagenesis Global Market Report 2023 - Vimarsana News

Cloning And Mutagenesis Global Market Report 2023

Major players in the cloning and mutagenesis market are Thermo Fisher Scientific, Takara Bio Inc., Agilent Technologies Inc., Jena Bioscience GmbH,...

Nikko Asset Management Americas Inc. Grows Stock Position in Twist Bioscience Co. (NASDAQ:TWST) - Vimarsana News

Nikko Asset Management Americas Inc. Grows Stock Position in Twist Bioscience Co. (NASDAQ:TWST)

Nikko Asset Management Americas Inc. grew its position in Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 15.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,401,914 shares of the company’s stock after acquiring an additional 467,881 shares during […]

Source: wkrb13.com
Twist Bioscience and Cancer Research Horizons announce new collaboration - Vimarsana News

Twist Bioscience and Cancer Research Horizons announce new collaboration

Twist Bioscience, a biotech company manufacturing synthetic DNA, and Cancer Research Horizons, the innovation engine at the core of Cancer Research UK, have announced an agreement under which Cancer Research Horizons will license the entire Twist Biopharma Solutions Library of Libraries.

Elevating Whole Exome Sequencing With Twist Exome 2.0 - Asian Scientist Magazine - Vimarsana News

Elevating Whole Exome Sequencing With Twist Exome 2.0 - Asian Scientist Magazine

Designed with best-in-class features, Twist Bioscience’s Exome 2.0 outperforms other exome sequencing panels in detecting rare and inherited diseases.